EUVIMEDAvasta EUVIMED
Crossref

Hemodynamic Impact of Vasopressor Therapy in Critically Ill Patients with Septic Shock in the Intensive Care Unit

Francisco Luis Díaz Ramírez, Jose David Alvarez Rodriguez

IECCMEXICO · 2026-06-27 · 4 (1)

DOI: 10.64784/224 ↗

At a glance

Journal article in IECCMEXICO, published online on 2026-06-27. Written by Francisco Luis Díaz Ramírez and 1 co-authors.

AbstraktBibliograafilised andmedCiteRelated studies

Abstract (original language)

Septic shock remains one of the leading causes of mortality among critically ill patients admitted to intensive care units worldwide. Profound vasodilation, circulatory dysfunction, and impaired tissue perfusion frequently necessitate the use of vasopressor therapy to restore hemodynamic stability and preserve organ function. This review analyzes the current evidence regarding the hemodynamic impact of vasopressor therapy in adult patients with septic shock, with particular emphasis on clinical experiences and healthcare systems across the American continent. Scientific literature from major biomedical databases was examined to evaluate the physiological effects, therapeutic efficacy, safety profiles, and clinical outcomes associated with commonly used vasoactive agents, including norepinephrine, vasopressin, epinephrine, dopamine, phenylephrine, and angiotensin II. The findings indicate that norepinephrine remains the preferred first-line vasopressor due to its favorable balance between efficacy and safety. Early vasopressor initiation was consistently associated with improved hemodynamic stabilization, reduced duration of hypotension, and enhanced tissue perfusion. Adjunctive therapies such as vasopressin and angiotensin II demonstrated potential benefits in selected patients with refractory vasodilatory shock. The review also highlights the importance of individualized blood pressure targets, integration of microcirculatory assessment, and adherence to evidence-based sepsis protocols. Furthermore, regional differences in critical care resources, medication availability, and healthcare infrastructure were identified as important factors influencing outcomes throughout the Americas. The available evidence supports the implementation of personalized vasopressor strategies combined with comprehensive critical care management to improve survival and reduce organ dysfunction in patients with septic shock.

Cite

APA

Ramírez, F. L. D., & Rodriguez, J. D. A. (2026). Hemodynamic Impact of Vasopressor Therapy in Critically Ill Patients with Septic Shock in the Intensive Care Unit. IECCMEXICO, 4(1). https://doi.org/10.64784/224

Vancouver

Ramírez FLD, Rodriguez JDA. Hemodynamic Impact of Vasopressor Therapy in Critically Ill Patients with Septic Shock in the Intensive Care Unit. IECCMEXICO. 2026;4(1). doi:10.64784/224

BibTeX
@article{Ramrez2026,
  author = {Ramírez, Francisco Luis Díaz and Rodriguez, Jose David Alvarez},
  title = {Hemodynamic Impact of Vasopressor Therapy in Critically Ill Patients with Septic Shock in the Intensive Care Unit},
  journal = {IECCMEXICO},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.64784/224}
}
Start for free →